Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 18 medicines
- Adderall XR 102.5MG; 2.5MG; 2.5MG; 2.5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 153.75MG; 3.75MG; 3.75MG; 3.75MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 205MG; 5MG; 5MG; 5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 256.25MG; 6.25MG; 6.25MG; 6.25MG · capsule, extended release · Takeda Pharms USA
All medicines with Amphetamine aspartate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
27 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateCombination | United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Marketed | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateCombination | United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Marketed | Ani Pharms |
| Adderall XR 5Combination | United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 10Combination | United States | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 15Combination | United States | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 20Combination | United States | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 25Combination | United States | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 30Combination | United States | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Dextroamp Saccharate,Amp Aspartate,Dextroamp Sulfate and Amp SulfateCombination | United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG, 3.75MG; 3.75MG; 3.75MG; 3.75MG … | capsule, extended release | Not marketed | Barr Labs INC |
| MydayisCombination | United States | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall 5Combination | United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 10Combination | United States | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 15Combination | United States | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 20Combination | United States | 5MG; 5MG; 5MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 30Combination | United States | 7.5MG; 7.5MG; 7.5MG; 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 7.5Combination | United States | 1.875MG; 1.875MG; 1.875MG; 1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 12.5Combination | United States | 3.125MG; 3.125MG; 3.125MG; 3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Dextroamphetamine Saccharate; Amphetamine Aspartate Monohydrate; Dextroamphetamine Sulfate; Amphetamine SulfateCombination | United States | 10MG, 15MG, 20MG … | capsule, extended release | Tentative approval | Corepharma |
| Amphetamine | United States | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Marketed | Actavis Labs FL INC |
| Amphetamine Sulfate | United States | 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG … | tablet | Marketed | Granules |
| Dyanavel XRCombination | United States | 2MG/ML; 0.5MG BASE/ML | suspension, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 10Combination | United States | 8MG; 2MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 15Combination | United States | 12MG; 3MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 20Combination | United States | 16MG; 4MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 5Combination | United States | 4MG; 1MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 18
- Companies
- 6